(Q43505733)

24 November 2017

Identification of enzymes responsible for rifalazil metabolism in human liver microsomes (English)

1 reference

24 November 2017

Mae T

1

1 reference

24 November 2017

Inaba T

2

1 reference

24 November 2017

Konishi E

3

1 reference

24 November 2017

Hosoe K

4

1 reference

24 November 2017

Hidaka T

5

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

24 November 2017

1 reference

24 November 2017

30

1 reference

24 November 2017

6

1 reference

24 November 2017

565-574

1 reference

Serum esterases. I. Two types of esterase (A and B) hydrolysing p-nitrophenyl acetate, propionate and butyrate, and a method for their determination

24 November 2017

1 reference

https://api.crossref.org/works/10.1080%2F004982500406408

Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982500406408

Urinary metabolites of rifabutin, a new antimycobacterial agent, in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982500406408

In vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982500406408

Metabolism of rifabutin in human enterocyte and liver microsomes: kinetic parameters, identification of enzyme systems, and drug interactions with macrolides and antifungal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982500406408

Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982500406408

In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982500406408

In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982500406408

Clinical significance of esterases in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982500406408

Synthesis and biological activity of 3'-hydroxy-5'-aminobenzoxazinorifamycin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982500406408

Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982500406408

HIV protease inhibitors, saquinavir, indinavir and ritonavir: inhibition of CYP3A4-mediated metabolism of testosterone and benzoxazinorifamycin, KRM-1648, in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982500406408

Effect of a new rifamycin derivative, rifalazil, on liver microsomal enzyme induction in rat and dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982500406408

Isolation and identification of major metabolites of rifalazil in mouse and human

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982500406408

Relationship between mRNA levels quantified by reverse transcription-competitive PCR and metabolic activity of CYP3A4 and CYP2E1 in human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982500406408

Identification of urinary metabolites of rifamycin LM 427 in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F004982500406408

21 January 2018

Identifiers

DOI

10.1080/004982500406408

1 reference

24 November 2017

1 reference